BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on medicinal products containing pioglitazone (actos®, Competact®, Tandemact®): Increased incidence of bladder cancer

Active substance: pioglitazone

Important safety information on the use of medicinal products containing pioglitazone.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 178KB, File is accessible